|
HS Code |
985132 |
| Chemical Name | 4-Methylsalicylamide |
| Cas Number | 50-86-2 |
| Molecular Formula | C8H9NO2 |
| Molecular Weight | 151.17 g/mol |
| Iupac Name | 4-methyl-2-hydroxybenzamide |
| Appearance | White to off-white solid |
| Melting Point | 160-163°C |
| Boiling Point | 370.6°C at 760 mmHg |
| Density | 1.27 g/cm3 |
| Solubility In Water | Slightly soluble |
| Smiles | CC1=CC=C(C=C1O)C(=O)N |
| Pubchem Cid | 8111 |
As an accredited 4-Methylsalicylamide factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The 100g package of 4-Methylsalicylamide comes in a sealed amber glass bottle with a tamper-evident screw cap and detailed labeling. |
| Shipping | 4-Methylsalicylamide is typically shipped in tightly sealed containers to prevent moisture and contamination. It should be packaged in accordance with local and international chemical transport regulations, labeled with appropriate hazard information if required. During transit, keep the chemical away from incompatible substances and ensure storage in a cool, dry environment. |
| Storage | 4-Methylsalicylamide should be stored in a tightly sealed container, kept in a cool, dry, and well-ventilated area away from sources of heat, ignition, and direct sunlight. Store separately from strong oxidizers and acids to prevent hazardous reactions. Properly label storage containers, and ensure access is limited to trained personnel. Follow all local, state, and federal chemical storage regulations. |
Applications of 4-Methylsalicylamide in Industrial Manufacturing4-Methylsalicylamide acts as a key specialty intermediate for several industrial chemical processes. As a manufacturer, we support downstream clients with high-purity material for use in advanced applications, ensuring strict compliance and process reliability. Below, we break down its main industrial uses, each comprising unique integration and compliance demands. 1. Pharmaceutical Intermediate for Analgesic and Antipyretic APIsDownstream pharmaceutical producers utilize 4-methylsalicylamide as an intermediate in the multi-step synthesis of certain analgesic and antipyretic active ingredients. The compound often enters amidation or N-alkylation stages, supporting the construction of substituted benzamide scaffolds critical for final API synthesis. Manufacturers must adhere to pharmacopeial requirements and maintain stringent impurity control throughout the process to ensure finished APIs meet international safety and efficacy benchmarks for end-use medicines. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Agrochemical Synthesis for Fungicide Building BlocksLeading agrochemical companies integrate 4-methylsalicylamide early in the multi-stage synthesis of several patented and generic fungicidal agents. The material’s amide functional group enables downstream formation of active triazole or strobilurin scaffolds, essential in broad-spectrum fungicide production. Due to the agricultural regulatory environment, processors must provide complete batch traceability and residual impurity data for each synthesis batch, ensuring compliance with global pesticide standards. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Dye and Pigment Intermediate for Fluorescent Compounds4-Methylsalicylamide serves as a critical precursor in the production of certain fluorescent dyes for industrial marking, security inks, and specialty pigment applications. The molecule’s amide and methyl substituents permit downstream functionalization to form high-purity, light-fast dyes. This industry requires precise control of impurity profiles and batch color consistency, with applications subject to chemical safety and export control regulations in several regions. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Chemical Auxiliary in Fine Fragrance SynthesisPerfume and aroma chemical producers employ 4-methylsalicylamide as a structure-modifying agent in select synthetic fragrances, particularly for musk and woody aroma compounds. The amide group alters molecular polarity and scent profile, supporting designer formulations. Production must meet IFRA and cosmetic-grade quality standards, requiring trace metals and contaminant screening, as well as full batch documentation for international shipment and use. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Specialty Resin and Polymer ModificationManufacturers of specialty polymers and resins use 4-methylsalicylamide as a chain modifier and cross-linking agent in the production of engineering plastics and high-performance resins. The aromatic amide structure enables tuning of mechanical and thermal properties for demanding applications such as electronic encapsulants and automotive coatings. Stringent control of residuals ensures compliance with industrial and environmental management systems, safeguarding batch reproducibility and downstream product longevity. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
6. Laboratory Reagent and Analytical Reference MaterialChemical and pharmaceutical analysis laboratories use 4-methylsalicylamide as a certified reference standard and derivatization reagent in chromatographic and spectroscopic analysis of related salicylamide derivatives. The compound supports method validation for both qualitative structure confirmation and quantitative impurity analysis. Laboratories require full traceability on purity and source, with conformance to analytical calibration material procedures and safe handling guidelines. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 4-Methylsalicylamide prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Producing 4-Methylsalicylamide does not just happen by mixing a few reagents. It’s a process that benefits from years of running pilot batches, optimizing pH, and finely tuning crystallization steps—the sort of operational detail clear to any serious chemical manufacturer. Over many production cycles, we have identified the fine points that make a difference between standard product and repeatable, consistent quality. We charge every batch with confidence because we approach this process with discipline, not shortcuts. This compound, recognized for its utility in pharma and beyond, reaches the market from the lab benches and steel reactors of those who invest in ongoing process refinement, not from a stock photo or spreadsheet.
We have learned over the years that the chemistry textbook never tells the whole story. Every kilogram of 4-Methylsalicylamide coming off the final filter reflects decisions made based on real-world lab data rather than theoretical yield or generic specifications. Only patient drying and careful mother liquor management produce a consistent, freely flowable white powder, with a solid melting point range around 158-160°C. We constantly examine each lot’s purity (usually over 99.5% by HPLC), controlling for trace organic and inorganic contaminants, because any residue can undermine downstream reactions. These are not sales points—they are features only possible to guarantee by handling the compound at all stages, right through to final drum or polyethylene bag packaging.
4-Methylsalicylamide carries a methyl group at the para position on the salicylamide backbone, an often-overlooked nuance. Customers in the pharmaceutical sector value this subtlety as it influences solubility, reactivity, and downstream derivatization. Having handled related compounds such as ortho- and meta-methyl analogs, we see the real-world impact of this particular molecular arrangement during API intermediate production or formulation design. Each position on the molecule plays its own role: imagine troubleshooting a new benzoic acid derivative synthesis, only to find side reactions popping up when switching from 4-methyl to 3-methyl versions. Experience tells us these differences dictate process efficiency and cost over entire project timelines.
Customers buying 4-Methylsalicylamide straight from manufacturing operations judge us on product fidelity. We have heard from formulation chemists who encounter caking or unexpected melting points from poorly produced material, which can stall scale-up or force reformulation late in a project. Our internal QC team measures not just melting point and purity but also bulk density, particle size distribution, and moisture content. Fielding sample feedback led us to switch to double-bagging with a desiccant in the packaging line for moisture-sensitive orders, for example. That physical off-white powder that slides out of the drum reflects a dozen choices made upstream on the production floor—not just a spec sheet or a faceless batch code.
In our experience, 4-Methylsalicylamide behaves well in most standard organic synthesis environments, dissolving easily in warm ethanol, acetone, and basic aqueous solutions. During scale-up, solubility at various temperatures becomes critical, and we have recorded our own data to guide customers: at room temperature, water solubility remains modest, so we recommend moderate warming or cosolvent addition to ensure full dissolution on batch mixing. Many customers have commented on the minimal dust when opening new containers—a small but important benefit of consistent particle size distribution, which matters most on busy industrial benches where respirable powders create safety headaches.
Repeated requests from medicinal chemists pushed us to refine our purification methods. Trace contaminants found at levels below those impacting routine chemical synthesis may still influence bioassay screens. Over time, we adjusted our process for a higher level of clarity, especially for customers preparing preclinical material. Rather than simply meeting a high-purity threshold, we examine specific impurity profiles—including possible isomerization products and benzamide derivatives that might arise in side reactions. This effort pays off in feedback: researchers report fewer surprises down the line, and pilot plant engineers report smoother transitions from gram to kilogram scale.
Those new to 4-Methylsalicylamide may come with experience handling standard salicylamide or different ring-substituted versions. Direct comparison on our own benches reveals the practical differences: unmethylated salicylamide tends to form slightly larger crystals during recrystallization, and its hydrogen bonding pattern encourages greater water uptake during humid storage. The methyl group at position 4 blocks this effect to some degree, producing a more stable product in environments where tableting or dry blending matters. Customers switching from the unsubstituted product report easier process flow and better stability, especially during long-term storage or transport. Other analogs, such as 3-methylsalicylamide, give different UV-Vis spectra and melting point behavior, which can confound routine QC unless clearly distinguished.
By keeping control of sourcing, manufacturing, and lot release, we back every batch of 4-Methylsalicylamide with first-hand quality assurance. Certificates of Analysis come paired with our detailed back-of-the-lab-notebook observations—ranging from lot-specific crystallization rates to nuanced remarks on aroma or handling cues that we have noticed, which rarely appear in formal documentation. For customers scaling up from the bench, these practical notes allow a level of troubleshooting not available with catalog suppliers or intermediates shipped without traceability. If a downstream process throws a curveball, we know what might have changed from one batch to the next, because all process data is kept within the same plant walls.
Our organization started out supplying kilogram lots to development laboratories but quickly faced requests for hundred-kilogram and even multi-ton quantities. This jump did not simply mean pouring larger flasks—it meant overhauling filtration systems, upgrading solvent recovery, and investing in industrial dryers. Each scale brings its own challenges. For example, the exotherm managed without issue in a two-liter flask can foam unexpectedly at fifty times the volume. We guarantee batch-to-batch reproducibility because we document and adapt every procedural shift. Users working at the pilot stage can visit our plant, speak to our operators, and see real material moving through the equipment—not just a pretty label in a catalog.
Those who work directly with 4-Methylsalicylamide at scale know the practical pitfalls: powder bridging in hoppers, slow filtration rates during product isolation, sticky clumping during drying if not handled with care. Over the years, feedback from formulation teams in both pharma and specialty chemicals has been integral. A key improvement based on real processing headaches was relocating the spray-dry nozzles in our fluid bed drier to limit residence time and prevent excessive compaction. Simple changes such as finer mesh sieving before packaging have reduced caking during shipment in humid climates. When end-users share challenges back with us, we engineer fixes into our next production cycle, closing the loop faster than any reseller chain.
On the safety front, handling methylated amides in a production environment brings occupational challenges. Unlike simple benzoic acid derivatives, this compound produces negligible odor, but fine dust still calls for dust collection and personal protective measures. While classified as low-hazard, we maintain rigorous training for plant personnel on transfer, waste segregation, and emission control. Our solvent recovery systems run with containment protocols, tuned from operational experience rather than generic safety handbooks. As regulations evolve, every waste solvent and mother liquor gets tracked, segregated, and neutralized according to both current rules and best practices derived from our own plant audits.
As origin and batch traceability rise in importance across the globe, manufacturers who run their own plants stand apart. End-users in regulated sectors demand full transparency on synthetic history, material life-cycle, and purity control. By controlling all upstream chemistry and plant logistics, we hand over not just a Certificate of Analysis, but the entire production chain—from raw material origin to vessel cleaning logs and packing checklists. If a customer in another country seeks root-cause analysis for a synthesis failure, we trace the entire batch history down to reactor temperatures and hold times, not just mass balance figures.
4-Methylsalicylamide has established itself as a versatile intermediate in several chemical sectors, but its main value comes to light when moving ideas from research to scaled manufacturing. In pharmaceuticals, the functional group arrangement makes it a go-to building block for certain non-steroidal anti-inflammatory drugs and experimental APIs. Outside medicine, it has cropped up as a fine chemical precursor for photographic chemicals, agrochemicals, and dyes. Frequent requests for custom impurity profiling from startup biotech firms and multinational pharma giants reflect the compound’s broad appeal—each with their own specs, but all depending on reliable underlying chemistry, robust purification, and honest communication directly from the source.
The single best way to improve 4-Methylsalicylamide from a manufacturing point-of-view comes through real user testing, not just in-house research. Routine conversations with formulation labs have steered us toward optimized drying protocols, while process engineers have nudged us to streamline our bulk transfer and drum-filling approaches. Not long ago, a customer’s unusual problem with clumping during high humidity led us to refine our ambient humidity controls in final packaging—and publish new recommended storage conditions. Lab-based suggestions, whether about particle flow under pressure or improved labeling clarity, get implemented at the plant level and checked for real results.
It is one thing to read a theoretical comparison between 4-Methylsalicylamide and similar amides on paper, and another to see differences in actual processing performance. Our plant team sees every small quirk—such as bottle-neck flow in tablet press feeds, slightly different compressibility versus unsubstituted or ortho-methyl variants, or subtle color changes in long-term storage under warehouse lighting. We spot lot-to-lot color variations sometimes as a shift in light cream hue, not always detected by electronic sensors but caught by the eyes of operators who have poured out drums week after week. Customers count on this accumulated know-how to avoid wasted time and product during critical runs.
By the time 4-Methylsalicylamide leaves the plant, we have verified every drum, pail, or sack—sealed, labeled, and shipped under conditions that match user storage environments. Each lot gets wrapped and palletized by operators who have already participated in sampling and quality sign-off, rather than part-timers on a pseudo-automated line. If a shipment crosses climates or customs, we supply temperature, humidity, and handling advice rooted in hard-won experience. Our commitment to the end-user goes beyond a sale—we remain on call to resolve unexpected challenges in transit, customs clearance, or warehousing, sharing practical solutions learned from decades of hands-on shipments.
We believe in an open-door policy for customers and regulatory partners. Prospective clients, whether a small R&D lab or a multinational pharma team, can tour our production areas, ask questions, and review any stage of the process. We do not rely on catalog claims or paper-thin audits; instead, we provide transparency in both process and documentation, confident that our process holds up under scrutiny. This way, any unexpected variation or compliance question can be met with direct evidence from our actual operations—not guesses or templates.
Decades of specialization in amide chemistry—including work with 4-Methylsalicylamide—taught us that reliability is never an accident. It comes from open lines of communication between manufacturers and end-users, detailed documentation, process ownership, and relentless attention to detail. We take every batch seriously because the real test of manufacturing is performance on your benches, in your reactors, and through your downstream processing. Working as chemical makers, we build trust one lot at a time, sharing results, challenges, and fixes as an ongoing partnership rather than a one-off transaction.
No matter whether you develop the next pharmaceutical breakthrough or optimize specialty chemical processes, the importance of material traceability and composition stands front and center. With 4-Methylsalicylamide from a proven manufacturing pipeline, you receive more than an isolated compound—you connect directly to a knowledge base grounded in experience, flexible enough to suit evolving needs yet stable enough to underpin reliable commercial activity. You deal directly with operators, process chemists, and QC analysts focused on long-term partnership, not just order fulfillment. From gram to drum, each package carries the benefit of direct manufacturer oversight, and every inquiry finds an answer supported by empirical data and years of practical problem-solving.